What is coronary steal syndrom

Reading File
Searching the Web

coronary steal syndrome mechanism pathophysiology

Finding Sources
Reading File
Reading File
Reading File
Here is a thorough breakdown of coronary steal syndrome drawing from multiple authoritative textbooks:

Coronary Steal Syndrome

Definition

Coronary steal syndrome is the paradoxical worsening of myocardial ischemia caused by vasodilation. When a coronary vasodilator is administered, blood flow is diverted ("stolen") away from ischemic zones of the myocardium into normal, well-perfused regions - because ischemic zones are already maximally vasodilated and cannot dilate further.
  • Katzung's Basic and Clinical Pharmacology, 16e

Why It Happens: The Core Mechanism

Under normal (resting) conditions, a region of myocardium supplied by a stenosed coronary artery compensates by:
  1. Maximally dilating the downstream arterioles, minimizing local vascular resistance to preserve flow.
  2. Developing collateral vessels that route blood around the obstruction from a "donor" artery (the non-stenosed vessel).
This balance is fragile. When a potent non-selective coronary arteriolar dilator (like dipyridamole or adenosine) is given:
  • The arterioles in well-perfused regions (which still have vasodilatory reserve) dilate widely, dramatically reducing resistance and increasing flow in those territories.
  • The arterioles in ischemic regions are already maximally dilated - they have no further reserve.
  • The resulting drop in perfusion pressure across the collateral vessels reverses or reduces the pressure gradient that was driving blood to the ischemic zone.
  • Blood is effectively "stolen" from the ischemic zone into the normal zone.
"If a potent arteriolar dilator is administered, only the vessels in the well-perfused regions are capable of further dilation, so more flow is diverted ('stolen') from the ischemic region into the normal region."
  • Katzung's Basic and Clinical Pharmacology, 16e, p. 318

Two Anatomical Subtypes

1. Transmural (Subendocardial) Steal

In a single artery with a significant stenosis:
  • The subepicardial vessels (outer layer) dilate in response to the drug.
  • This reduces perfusion pressure distal to the stenosis.
  • The subendocardial vessels (inner layer, already pressure-dependent due to wall stress) receive even less flow, precipitating subendocardial ischemia.

2. Collateral Steal (True Collateral Steal)

  • A "donor" artery (normal) and a "recipient" territory (supplied via collaterals from the donor, past a stenosed artery) exist in parallel.
  • Vasodilation of the donor artery's distal bed reduces pressure at the collateral origin.
  • The driving pressure gradient for collateral flow drops, and the ischemic territory is underperfused.
  • ScienceDirect / Coronary Steal Overview

Drugs That Cause Coronary Steal

DrugMechanism
DipyridamoleInhibits adenosine uptake → accumulation of adenosine → arteriolar dilation; classic coronary steal agent
AdenosineDirectly activates A2A receptors → marked coronary arteriolar dilation; labeled with steal warnings
RegadenosonSelective A2A agonist; same risk; used in pharmacologic stress testing
IsofluranePotent volatile anesthetic with coronary vasodilatory properties - was controversial in 1980s-90s; largely not clinically significant
Sodium NitroprussideIntra-myocardial vasodilation possible; not recommended in active myocardial ischemia
Katzung's Basic and Clinical Pharmacology, 16e; Braunwald's Heart Disease; Miller's Anesthesia, 10e

Diagnostic Use (Pharmacologic Stress Testing)

Ironically, coronary steal is intentionally exploited for diagnosis. Patients who cannot exercise physically are given dipyridamole, adenosine, or regadenoson. The induced steal produces ischemia in territories with coronary artery disease, which is then detected by:
  • Nuclear perfusion imaging (SPECT/PET)
  • Stress echocardiography (new wall motion abnormalities)
  • ECG changes (ST depression)
"Dipyridamole is thus a pharmacological success diagnostically, but a therapeutic failure because of the coronary steal phenomenon."
  • Wikipedia/Coronary Steal

Clinical Consequences

  • Stable angina: Exacerbation of ischemia, anginal symptoms
  • Unstable angina: Transient coronary steal from dipyridamole or adenosine may precipitate myocardial infarction - these drugs are contraindicated
  • ALCAPA (Anomalous Left Coronary Artery from Pulmonary Artery): A structural form of coronary steal - reduced pulmonary artery pressure causes reversal of flow in the anomalous left coronary, stealing blood away from the LV myocardium, causing infantile heart failure and one of the most common causes of myocardial infarction in infants - Tintinalli's Emergency Medicine
  • Coronary artery fistulas: The fistula diverts blood away from myocardium, causing angina - Goldman-Cecil Medicine

Key Teaching Point

The pathophysiology hinges on two parallel vascular beds, both distal to a stenosis:
  • One bed (normal): has vasodilatory reserve, can dilate further
  • Other bed (ischemic): already maximally dilated, perfusion pressure-dependent
Any drop in upstream pressure (from vasodilation of the normal bed) directly reduces flow to the ischemic bed. This is why vasodilators worsen ischemia rather than help it in this setting.

Sources: Katzung's Basic and Clinical Pharmacology 16e; Barash Clinical Anesthesia 9e; Braunwald's Heart Disease; Miller's Anesthesia 10e; Goldman-Cecil Medicine; Tintinalli's Emergency Medicine; Lippincott Pharmacology
This is a shared conversation. Sign in to Orris to start your own chat.